|
|
|
|
|
|
|
Articles by keyword
medicines
Call for all civil society groups, people living with HIV, all communities facing communcable, chronic and/or non-communicable diseases in the TPPA signatory countries to join forces to halt any & all trade agreements that restrict access to generic medicines.
New trade agreement threatens Australia’s laws on medicines and tobacco
| 1-September-2011
Australia leads the world in many areas of public health but the Federal Government could be negotiating our achievements away, according to Dr Patricia Ranald, Convenor, Australian Fair Trade and Investment Network 
Last week, a group of seven House Democrats, led by Rep. Henry Waxman (D-CA), sought to have the 12-year data exclusivity period provided by the biosimilar approval pathway of the US’ Patient Protection and Affordable Care Act excluded from the Trans-Pacific Partnership agreement 
India’s Department of Pharmaceuticals will take up issues with the Commerce Ministry regarding the proposed Trans Pacific Partnership Agreement which is likely to have adverse impact on the Indian pharma products, and other such Free Trade Agreements in the pipeline. 
The new strategy is to treat people in Egypt, Paraguay, Turkmenistan or China — middle-income countries, all — as if they or their governments could pay hundreds or even thousands of dollars a year each for AIDS drugs.
Impact Assessment of CETA IPR chapter
| 25-July-2011
CETA IPR chapter will likely have a slight positive effect on specific industries in the EU, such as agri-food companies using geographical indications. It would also benefit the Canadian publishing industry and the innovative pharmaceutical industry. At the same time, an IPR chapter in CETA could lead to notable negative effects in Canada, for example via higher prices on educational and pharmaceutical products.
Président de l’IAS pour plus de facilités d’accès aux médicaments contre le sida
| 18-July-2011
Le président de l’Association Internationale du Sida (IAS), l’Ougandais Elly Katabira, a invité dimanche, tous les pays du monde de faciliter l’accès aux médicaments contre la maladie, y compris les génériques, par des nouvelles lois ou règlements.
SOCMA offers support for free trade pacts with South Korea, Panama, and Colombia
| 17-July-2011
The Society of Chemical Manufacturers and Affiliates (SOCMA) issued its support this week of the passage of pending free-trade agreements (FTA) with South Korea, Panama and Colombia by two Congressional committees. SOCMA is the US-based trade association representing custom and batch manufacturers, including contract manufacturers of fine chemicals, pharmaceutical intermediates, and active pharmaceutical ingredients. 
Conflict between European and Indian pharma industries might be played out again in FTAs with other nations
"BRICS can ensure affordable drugs"
| 10-July-2011
While ‘data exclusivity’ clauses will not feature in the India-European Union free trade agreement (FTA), the threat posed by the impending deal to the world’s supply of cheap generic drugs is far from over.
Korea-EU FTA to put Seoul at public health crossroads
| 8-July-2011
Pharmaceuticals might not have been the most discussed sector before the Korea-European Union Free Trade Agreement came into effect from July 1. 
Millions of people dependent on life-saving generic drugs to treat HIV/AIDS will die if India stops producing cheap drugs for the disease due to its trade deal with the European Union, the head of UNAIDS warned on Tuesday. 
This morning, in a small town in the region of Gent, Belgium, activists from Act Up-Paris woke up the European Commissioner for Trade in front of his house. They unfurled a banner which said ‘De Gucht, AIDS accomplice’.
EEUU - DR-CAFTA: TLC encarece medicamentos
| 29-June-2011
El relator especial de las Naciones Unidas sobre el Derecho a la Salud, Anand Grover, detectó el aumento en el precio de algunos medicamentos, debido al TLC con EE. UU., y sugiere la compra de fármacos genéricos. 
One of WikiLeaks’ greatest achievements has been to expose the exorbitant amount of influence that multinational corporations have over Washington’s diplomacy. 
The Asia Pacific Network of Positive People (APN+) is expressing outrage at ongoing free trade agreement negotiations by the United States with Vietnam and Malaysia that threaten access to medicines for HIV, TB, hepatitis-C as well as other diseases in these countries. 
Statement of May 2011 against the increasingly rapid spread of Free Trade Agreements that put the profits of multinational pharmaceutical companies ahead of people’s right to health around the world. 
India formally announced at the UN High
Shape of US TPP pharmaceuticals chapter emerges
| 16-June-2011
The TPP chapter may be best seen as a significant step toward the pharmaceutical industry’s ultimate goal, which is a binding international agreement on drug pricing that would restrain the ability of governments to use collective purchasing power to demand prices below “market” levels.
Pharmac trade row heralds wider threat
| 9-June-2011
Pharmac is being targeted by US drug companies as trade negotiations continue with the United States. |
L’accord entre l’Union Européenne et l’Inde menace l’accès aux traitements en Afrique du Nord et au Moyen-Orient
| 12-April-2013
|
